 | | ZVR | | Name: | N-{4-[3-(2-amino-4-oxo-3,4-dihydro-5H-pyrrolo[3,2-d]pyrimidin-5-yl)propyl]-2-fluorobenzoyl}-L-glutamic acid | | Formula: | C21 H22 F N5 O6 | | SMILES: | O=C(O)C(CCC(=O)O)NC(=O)c1ccc(cc1F)CCCn1ccc2N=C(N)NC(=O)c21 | | InChi: | InChI=1S/C21H22FN5O6/c22-13-10-11(2-1-8-27-9-7-14-17(27)19(31)26-21(23)25-14)3-4-12(13)18(30)24-15(20(32)33)5-6-16(28)29/h3-4,7,9-10,15H,1-2,5-6,8H2,(H,24,30)(H,28,29)(H,32,33)(H3,23,25,26,31)/t15-/m0/s1 | | Definition date: | 2023-04-06 | | Last modified: | 2024-03-15 | | Release date: | 2024-03-20 | | Identifier: | N-{4-[3-(2-amino-4-oxo-3,4-dihydro-5H-pyrrolo[3,2-d]pyrimidin-5-yl)propyl]-2-fluorobenzoyl}-L-glutamic acid |
|
 | | ZG5 | | Name: | 11-(4-beta-D-glucopyranuronosylpiperazin-1-yl)dibenzo[b,f][1,4]thiazepine | | Formula: | C23 H25 N3 O6 S | | SMILES: | O=C(O)C1OC(C(O)C(O)C1O)N1CCN(CC1)C1=Nc2ccccc2Sc2ccccc21 | | InChi: | InChI=1S/C23H25N3O6S/c27-17-18(28)20(23(30)31)32-22(19(17)29)26-11-9-25(10-12-26)21-13-5-1-3-7-15(13)33-16-8-4-2-6-14(16)24-21/h1-8,17-20,22,27-29H,9-12H2,(H,30,31)/t17-,18-,19+,20-,22+/m0/s1 | | Definition date: | 2023-03-09 | | Last modified: | 2024-03-15 | | Release date: | 2024-03-20 | | Identifier: | 11-(4-beta-D-glucopyranuronosylpiperazin-1-yl)dibenzo[b,f][1,4]thiazepine |
|
 | | HZA | | Name: | 2,5,8,11,14,17,20,23,26-nonaoxaoctacosane | | Formula: | C19 H40 O9 | | SMILES: | CCOCCOCCOCCOCCOCCOCCOCCOCCOC | | InChi: | InChI=1S/C19H40O9/c1-3-21-6-7-23-10-11-25-14-15-27-18-19-28-17-16-26-13-12-24-9-8-22-5-4-20-2/h3-19H2,1-2H3 | | Definition date: | 2018-07-30 | | Last modified: | 2024-03-15 | | Release date: | 2024-03-20 | | Identifier: | 2,5,8,11,14,17,20,23,26-nonaoxaoctacosane |
|
 | | A1AFY | | Name: | (R)-mevaldehyde | | Formula: | C6 H10 O4 | | SMILES: | CC(O)(CC=O)CC(O)=O | | InChi: | InChI=1S/C6H10O4/c1-6(10,2-3-7)4-5(8)9/h3,10H,2,4H2,1H3,(H,8,9)/t6-/m1/s1 | | Synonyms: | (3R)-3-hydroxy-3-methyl-5-oxopentanoic acid | | Definition date: | 2024-02-26 | | Last modified: | 2024-03-15 | | Release date: | 2024-03-20 | | Identifier: | (3R)-3-hydroxy-3-methyl-5-oxopentanoic acid |
|
 | | A1H3U | | Name: | 1-[[5-[5-(1~{H}-pyrazol-5-yl)pyridin-2-yl]oxypyridin-2-yl]methyl]piperidin-4-ol | | Formula: | C19 H21 N5 O2 | | SMILES: | OC1CCN(CC1)Cc2ccc(Oc3ccc(cn3)c4[nH]ncc4)cn2 | | InChi: | InChI=1S/C19H21N5O2/c25-16-6-9-24(10-7-16)13-15-2-3-17(12-20-15)26-19-4-1-14(11-21-19)18-5-8-22-23-18/h1-5,8,11-12,16,25H,6-7,9-10,13H2,(H,22,23) | | Synonyms: | LIPID FRAGMENT | | Definition date: | 2024-02-06 | | Last modified: | 2024-03-15 | | Release date: | 2024-03-20 | | Identifier: | 1-[[5-[5-(1~{H}-pyrazol-5-yl)pyridin-2-yl]oxypyridin-2-yl]methyl]piperidin-4-ol |
|
 | | A1H4E | | Name: | 4-[(3R)-3-methylmorpholin-4-yl]-2-[(2R)-2-(trifluoromethyl)piperidin-1-yl]-3H-pyridin-6-one | | Formula: | C16 H22 F3 N3 O2 | | SMILES: | C[CH]1COCCN1C2=CC(=O)N=C(C2)N3CCCC[CH]3C(F)(F)F | | InChi: | InChI=1S/C16H22F3N3O2/c1-11-10-24-7-6-21(11)12-8-14(20-15(23)9-12)22-5-3-2-4-13(22)16(17,18)19/h9,11,13H,2-8,10H2,1H3/t11-,13-/m1/s1 | | Definition date: | 2024-02-13 | | Last modified: | 2024-03-15 | | Release date: | 2024-03-20 | | Identifier: | 4-[(3~{R})-3-methylmorpholin-4-yl]-2-[(2~{R})-2-(trifluoromethyl)piperidin-1-yl]-3~{H}-pyridin-6-one |
|
 | | A1H4Q | | Name: | 5-(aminomethyl)-N-(3-chloranyl-1-methyl-indol-7-yl)-1,3-dihydroisoindole-2-sulfonamide | | Formula: | C18 H19 Cl N4 O2 S | | SMILES: | Cn1cc(Cl)c2cccc(N[S](=O)(=O)N3Cc4ccc(CN)cc4C3)c12 | | InChi: | InChI=1S/C18H19ClN4O2S/c1-22-11-16(19)15-3-2-4-17(18(15)22)21-26(24,25)23-9-13-6-5-12(8-20)7-14(13)10-23/h2-7,11,21H,8-10,20H2,1H3 | | Definition date: | 2024-02-15 | | Last modified: | 2024-03-15 | | Release date: | 2024-03-20 | | Identifier: | 5-(aminomethyl)-~{N}-(3-chloranyl-1-methyl-indol-7-yl)-1,3-dihydroisoindole-2-sulfonamide |
|
 | | A1H4R | | Name: | 3-[3-[2,3-bis(chloranyl)phenyl]-1H-pyrrolo[3,2-b]pyridin-6-yl]propan-1-amine | | Formula: | C16 H15 Cl2 N3 | | SMILES: | NCCCc1cnc2c([nH]cc2c3cccc(Cl)c3Cl)c1 | | InChi: | InChI=1S/C16H15Cl2N3/c17-13-5-1-4-11(15(13)18)12-9-20-14-7-10(3-2-6-19)8-21-16(12)14/h1,4-5,7-9,20H,2-3,6,19H2 | | Definition date: | 2024-02-15 | | Last modified: | 2024-03-15 | | Release date: | 2024-03-20 | | Identifier: | 3-[3-[2,3-bis(chloranyl)phenyl]-1~{H}-pyrrolo[3,2-b]pyridin-6-yl]propan-1-amine |
|
 | | A1H4S | | Name: | 3-[2,3-bis(chloranyl)phenyl]-5-methyl-6-(piperazin-1-ylmethyl)-1H-pyrrolo[3,2-b]pyridine | | Formula: | C19 H20 Cl2 N4 | | SMILES: | Cc1nc2c([nH]cc2c3cccc(Cl)c3Cl)cc1CN4CCNCC4 | | InChi: | InChI=1S/C19H20Cl2N4/c1-12-13(11-25-7-5-22-6-8-25)9-17-19(24-12)15(10-23-17)14-3-2-4-16(20)18(14)21/h2-4,9-10,22-23H,5-8,11H2,1H3 | | Definition date: | 2024-02-15 | | Last modified: | 2024-03-15 | | Release date: | 2024-03-20 | | Identifier: | 3-[2,3-bis(chloranyl)phenyl]-5-methyl-6-(piperazin-1-ylmethyl)-1~{H}-pyrrolo[3,2-b]pyridine |
|
 | | A1H4T | | Name: | (1S,5R)-8-[3-[2,3-bis(chloranyl)phenyl]-1H-pyrrolo[3,2-b]pyridin-6-yl]-8-azabicyclo[3.2.1]octan-3-amine | | Formula: | C20 H20 Cl2 N4 | | SMILES: | N[CH]1C[CH]2CC[CH](C1)N2c3cnc4c([nH]cc4c5cccc(Cl)c5Cl)c3 | | InChi: | InChI=1S/C20H20Cl2N4/c21-17-3-1-2-15(19(17)22)16-10-24-18-8-14(9-25-20(16)18)26-12-4-5-13(26)7-11(23)6-12/h1-3,8-13,24H,4-7,23H2/t11-,12-,13+ | | Definition date: | 2024-02-15 | | Last modified: | 2024-03-15 | | Release date: | 2024-03-20 | | Identifier: | (1~{S},5~{R})-8-[3-[2,3-bis(chloranyl)phenyl]-1~{H}-pyrrolo[3,2-b]pyridin-6-yl]-8-azabicyclo[3.2.1]octan-3-amine |
|
 | | A1D5N | | Name: | (3~{S})-5-methyl-3-[[1-pentan-3-yl-2-(thiophen-2-ylmethyl)benzimidazol-5-yl]carbonylamino]hexanoic acid | | Formula: | C25 H33 N3 O3 S | | SMILES: | CCC(CC)n1c(Cc2sccc2)nc3cc(ccc13)C(=O)N[CH](CC(C)C)CC(O)=O | | InChi: | InChI=1S/C25H33N3O3S/c1-5-19(6-2)28-22-10-9-17(25(31)26-18(12-16(3)4)14-24(29)30)13-21(22)27-23(28)15-20-8-7-11-32-20/h7-11,13,16,18-19H,5-6,12,14-15H2,1-4H3,(H,26,31)(H,29,30)/t18-/m0/s1 | | Synonyms: | CMF019 | | Definition date: | 2024-01-24 | | Last modified: | 2024-03-15 | | Release date: | 2024-03-20 | | Identifier: | (3~{S})-5-methyl-3-[[1-pentan-3-yl-2-(thiophen-2-ylmethyl)benzimidazol-5-yl]carbonylamino]hexanoic acid |
|
 | | WK2 | | Name: | (7M)-4-methyl-7-(4-methyl-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl)quinolin-2-amine | | Formula: | C20 H21 N3 O | | SMILES: | Nc1nc2cc(ccc2c(C)c1)c1ccc2OCCN(C)Cc2c1 | | InChi: | InChI=1S/C20H21N3O/c1-13-9-20(21)22-18-11-15(3-5-17(13)18)14-4-6-19-16(10-14)12-23(2)7-8-24-19/h3-6,9-11H,7-8,12H2,1-2H3,(H2,21,22) | | Definition date: | 2023-10-05 | | Last modified: | 2024-03-08 | | Release date: | 2024-03-13 | | Identifier: | (7M)-4-methyl-7-(4-methyl-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl)quinolin-2-amine |
|
 | | OD0 | | Name: | (1~{S},2~{R},3~{S},6~{S})-6-fluoranylcyclohex-4-ene-1,2,3-triol | | Formula: | C6 H9 F O3 | | SMILES: | O[CH]1C=C[CH](F)[CH](O)[CH]1O | | InChi: | InChI=1S/C6H9FO3/c7-3-1-2-4(8)6(10)5(3)9/h1-6,8-10H/t3-,4-,5+,6+/m0/s1 | | Definition date: | 2022-09-05 | | Last modified: | 2024-03-08 | | Release date: | 2024-03-13 | | Identifier: | (1~{S},2~{R},3~{S},6~{S})-6-fluoranylcyclohex-4-ene-1,2,3-triol |
|
 | | XZ0 | | Name: | (2~{S},5~{S})-4-[1-(4-chloranylpyridin-2-yl)piperidin-4-yl]-5-[(4-chlorophenyl)methyl]-2-methyl-morpholine | | Formula: | C22 H27 Cl2 N3 O | | SMILES: | C[CH]1CN(C2CCN(CC2)c3cc(Cl)ccn3)[CH](CO1)Cc4ccc(Cl)cc4 | | InChi: | InChI=1S/C22H27Cl2N3O/c1-16-14-27(21(15-28-16)12-17-2-4-18(23)5-3-17)20-7-10-26(11-8-20)22-13-19(24)6-9-25-22/h2-6,9,13,16,20-21H,7-8,10-12,14-15H2,1H3/t16-,21-/m0/s1 | | Definition date: | 2023-11-14 | | Last modified: | 2024-03-08 | | Release date: | 2024-03-13 | | Identifier: | (2~{S},5~{S})-4-[1-(4-chloranylpyridin-2-yl)piperidin-4-yl]-5-[(4-chlorophenyl)methyl]-2-methyl-morpholine |
|
 | | VB0 | | Name: | 5-(2-cyclopropylethynyl)-6-(2-fluorophenyl)pyrimidine-2,4-diamine | | Formula: | C15 H13 F N4 | | SMILES: | Nc1nc(N)c(C#CC2CC2)c(n1)c3ccccc3F | | InChi: | InChI=1S/C15H13FN4/c16-12-4-2-1-3-10(12)13-11(8-7-9-5-6-9)14(17)20-15(18)19-13/h1-4,9H,5-6H2,(H4,17,18,19,20) | | Definition date: | 2023-03-01 | | Last modified: | 2024-03-08 | | Release date: | 2024-03-13 | | Identifier: | 5-(2-cyclopropylethynyl)-6-(2-fluorophenyl)pyrimidine-2,4-diamine |
|
 | | YW5 | | Name: | 2-[(R)-(1H-benzimidazol-2-yl)(3-fluorophenyl)methyl]-6-[4-(1-methylpiperidin-4-yl)phenyl]-2,3-dihydro-1H-isoindol-1-one | | Formula: | C34 H31 F N4 O | | SMILES: | CN1CCC(CC1)c1ccc(cc1)c1ccc2CN(C(c3cccc(F)c3)c3nc4ccccc4[NH]3)C(=O)c2c1 | | InChi: | InChI=1S/C34H31FN4O/c1-38-17-15-24(16-18-38)22-9-11-23(12-10-22)25-13-14-27-21-39(34(40)29(27)20-25)32(26-5-4-6-28(35)19-26)33-36-30-7-2-3-8-31(30)37-33/h2-14,19-20,24,32H,15-18,21H2,1H3,(H,36,37)/t32-/m1/s1 | | Definition date: | 2023-02-27 | | Last modified: | 2024-03-08 | | Release date: | 2024-03-13 | | Identifier: | 2-[(R)-(1H-benzimidazol-2-yl)(3-fluorophenyl)methyl]-6-[4-(1-methylpiperidin-4-yl)phenyl]-2,3-dihydro-1H-isoindol-1-one |
|
 | | VBJ | | Name: | ~{N}-[3-[2,6-bis(azanyl)-5-(2-cyclopropylethynyl)pyrimidin-4-yl]phenyl]methanesulfonamide | | Formula: | C16 H17 N5 O2 S | | SMILES: | C[S](=O)(=O)Nc1cccc(c1)c2nc(N)nc(N)c2C#CC3CC3 | | InChi: | InChI=1S/C16H17N5O2S/c1-24(22,23)21-12-4-2-3-11(9-12)14-13(8-7-10-5-6-10)15(17)20-16(18)19-14/h2-4,9-10,21H,5-6H2,1H3,(H4,17,18,19,20) | | Definition date: | 2023-03-01 | | Last modified: | 2024-03-08 | | Release date: | 2024-03-13 | | Identifier: | ~{N}-[3-[2,6-bis(azanyl)-5-(2-cyclopropylethynyl)pyrimidin-4-yl]phenyl]methanesulfonamide |
|
 | | QW8 | | Name: | naphthalene-1,3,6,8-tetrol | | Formula: | C10 H8 O4 | | SMILES: | Oc1cc(O)c2c(O)cc(O)cc2c1 | | InChi: | InChI=1S/C10H8O4/c11-6-1-5-2-7(12)4-9(14)10(5)8(13)3-6/h1-4,11-14H | | Synonyms: | 1,3,6,8-tetrahydroxynaphthalene | | Definition date: | 2023-08-30 | | Last modified: | 2024-03-08 | | Release date: | 2024-03-13 | | Identifier: | naphthalene-1,3,6,8-tetrol |
|
 | | U56 | | Name: | N-hydroxycytidine | | Formula: | C9 H13 N3 O6 | | SMILES: | ONC1=NC(=O)N(C=C1)C1OC(CO)C(O)C1O | | InChi: | InChI=1S/C9H13N3O6/c13-3-4-6(14)7(15)8(18-4)12-2-1-5(11-17)10-9(12)16/h1-2,4,6-8,13-15,17H,3H2,(H,10,11,16)/t4-,6-,7-,8-/m1/s1 | | Definition date: | 2023-08-30 | | Last modified: | 2024-03-08 | | Release date: | 2024-03-13 | | Identifier: | N-hydroxycytidine |
|
 | | XL0 | | Name: | (7Z,19R,22S,25R)-22,25,26-trihydroxy-16,22-dioxo-17,21,23-trioxa-22lambda~5~-phosphahexacos-7-en-19-yl (9Z)-octadec-9-enoate | | Formula: | C40 H75 O10 P | | SMILES: | O=C(OC(COP(O)(=O)OCC(O)CO)COC(=O)CCCCCCC/C=CCCCCCC)CCCCCCC/C=CCCCCCCCC | | InChi: | InChI=1S/C40H75O10P/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-40(44)50-38(36-49-51(45,46)48-34-37(42)33-41)35-47-39(43)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2/h14,16-18,37-38,41-42H,3-13,15,19-36H2,1-2H3,(H,45,46)/b16-14-,18-17-/t37-,38-/m1/s1 | | Definition date: | 2022-11-28 | | Last modified: | 2024-03-08 | | Release date: | 2024-03-13 | | Identifier: | (7Z,19R,22S,25R)-22,25,26-trihydroxy-16,22-dioxo-17,21,23-trioxa-22lambda~5~-phosphahexacos-7-en-19-yl (9Z)-octadec-9-enoate |
|
 | | XMO | | Name: | N-hydroxy-5'-O-(2-methylpropanoyl)cytidine | | Formula: | C13 H19 N3 O7 | | SMILES: | CC(C)C(=O)OCC1OC(N2C=CC(=NC2=O)NO)C(O)C1O | | InChi: | InChI=1S/C13H19N3O7/c1-6(2)12(19)22-5-7-9(17)10(18)11(23-7)16-4-3-8(15-21)14-13(16)20/h3-4,6-7,9-11,17-18,21H,5H2,1-2H3,(H,14,15,20)/t7-,9-,10-,11-/m1/s1 | | Synonyms: | Molnupiravir | | Definition date: | 2023-08-30 | | Last modified: | 2024-03-08 | | Release date: | 2024-03-13 | | Identifier: | N-hydroxy-5'-O-(2-methylpropanoyl)cytidine |
|
 | | SYI | | Name: | 6-[diethylcarbamoyl(methyl)amino]-N-(1-methyl-1,2,3,4-tetrazol-5-yl)-2-(trifluoromethyl)pyridine-3-carboxamide | | Formula: | C15 H19 F3 N8 O2 | | SMILES: | CCN(CC)C(=O)N(C)c1ccc(C(=O)Nc2nnnn2C)c(n1)C(F)(F)F | | InChi: | InChI=1S/C15H19F3N8O2/c1-5-26(6-2)14(28)24(3)10-8-7-9(11(19-10)15(16,17)18)12(27)20-13-21-22-23-25(13)4/h7-8H,5-6H2,1-4H3,(H,20,21,23,27) | | Definition date: | 2023-04-19 | | Last modified: | 2024-03-08 | | Release date: | 2024-03-13 | | Identifier: | 6-[diethylcarbamoyl(methyl)amino]-~{N}-(1-methyl-1,2,3,4-tetrazol-5-yl)-2-(trifluoromethyl)pyridine-3-carboxamide |
|
 | | VF6 | | Name: | ~{N}-[4-[2,6-bis(azanyl)-5-(2-cyclopropylethyl)pyrimidin-4-yl]phenyl]ethanamide | | Formula: | C17 H21 N5 O | | SMILES: | CC(=O)Nc1ccc(cc1)c2nc(N)nc(N)c2CCC3CC3 | | InChi: | InChI=1S/C17H21N5O/c1-10(23)20-13-7-5-12(6-8-13)15-14(9-4-11-2-3-11)16(18)22-17(19)21-15/h5-8,11H,2-4,9H2,1H3,(H,20,23)(H4,18,19,21,22) | | Definition date: | 2023-03-06 | | Last modified: | 2024-03-08 | | Release date: | 2024-03-13 | | Identifier: | ~{N}-[4-[2,6-bis(azanyl)-5-(2-cyclopropylethyl)pyrimidin-4-yl]phenyl]ethanamide |
|
 | | VFF | | Name: | methyl 4-[2,6-bis(azanyl)-5-(2-cyclopropylethynyl)pyrimidin-4-yl]benzoate | | Formula: | C17 H16 N4 O2 | | SMILES: | COC(=O)c1ccc(cc1)c2nc(N)nc(N)c2C#CC3CC3 | | InChi: | InChI=1S/C17H16N4O2/c1-23-16(22)12-7-5-11(6-8-12)14-13(9-4-10-2-3-10)15(18)21-17(19)20-14/h5-8,10H,2-3H2,1H3,(H4,18,19,20,21) | | Definition date: | 2023-03-06 | | Last modified: | 2024-03-08 | | Release date: | 2024-03-13 | | Identifier: | methyl 4-[2,6-bis(azanyl)-5-(2-cyclopropylethynyl)pyrimidin-4-yl]benzoate |
|
 | | WRI | | Name: | (7M)-7-[(9S)-9-amino-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl]-4-methylquinolin-2-amine | | Formula: | C21 H23 N3 | | SMILES: | NC1CCCCc2ccc(cc21)c1cc2nc(N)cc(C)c2cc1 | | InChi: | InChI=1S/C21H23N3/c1-13-10-21(23)24-20-12-16(8-9-17(13)20)15-7-6-14-4-2-3-5-19(22)18(14)11-15/h6-12,19H,2-5,22H2,1H3,(H2,23,24)/t19-/m0/s1 | | Definition date: | 2023-10-10 | | Last modified: | 2024-03-08 | | Release date: | 2024-03-13 | | Identifier: | (7M)-7-[(9S)-9-amino-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl]-4-methylquinolin-2-amine |
|
